Medullary thyroid carcinoma – case reports

05/2021

MUDr. Andrea Jurečková

Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno

 

SUMMARY

Two case reports of patients with metastatic medullary thyroid carcinoma treated with tyrosine kinase inhibitors as a 1st line treatment are presented. The effectiveness of the treatment is compared - long-term treatment response in patient with early detected metastatic disease versus quick progression in patient with late diagnosis of advanced carcinoma and large proportion of metastatic lesions.

 

Key words

medullary thyroid carcinoma, targeted therapy, vandetanib, cabozantinib

 

 

The full article is only available to subscribers

Become a regular subscriber to our Oncological Review...

 

MORE ABOUT SUBSCRIPTION